MedTrace Logo

Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

NCT00416377 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 353

Last updated 2013-08-02

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill cancer cells. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.

PURPOSE: This clinical trial is studying how well radiation therapy or combination chemotherapy work in treating young patients with Hodgkin's lymphoma.

Conditions

Interventions

BIOLOGICAL

bleomycin sulfate

DRUG

chlorambucil

DRUG

dacarbazine

DRUG

doxorubicin hydrochloride

DRUG

prednisolone

DRUG

procarbazine hydrochloride

DRUG

vinblastine sulfate

DRUG

vincristine sulfate

RADIATION

radiation therapy

Sponsors & Collaborators

  • Children's Cancer and Leukaemia Group

    lead OTHER

Principal Investigators

  • Ann Barrett · University of Glasgow

  • Judith E. Kingston, MD · St. Bartholomew's Hospital

  • John Martin, MD · Royal Liverpool Children's Hospital, Alder Hey

Study Design

Purpose
TREATMENT
Masking
NONE

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00416377 on ClinicalTrials.gov